Looking Beyond Controlled Trials: The Economics of EHealth Commercialization
|
If you are the presenter of this abstract (or if you cite this abstract in a talk or on a poster), please show the QR code in your slide or poster (QR code contains this URL). |
Abstract
Background: Despite highly promising evidence of the reach and efficacy of eHealth and mHealth tools, there are relatively few profitable businesses working in the space. Recent peer-reviewed publications have attempted to illustrate a positive correlation between eHealth programs and Return on Investment (ROI), and business stakeholders and the investment community remain optimistic. But eHealth and mHealth businesses tend to find it difficult to achieve sustainability. Why?
Objectives: This presentation is designed to introduce researchers and innovators to two common barriers that hamper commercialization: transfer costs and opportunity costs. Successful businesses in the eHealth and mHealth space understand these costs. Businesses that do not are often forced to pivot (a term indicating that a company’s business model has changed), or simply cease to exist. Further, in order to attract investors and clients, it is important to understand the differences between Return on Investment (ROI), and Return on Invested Capital (ROIC).
Methods: By revisiting key milestones in the growth of Internet healthcare, this presentation will review the fundamentals of transfer and opportunity costs, and ROI and ROIC as they pertain to growth in this unique and evolving market.
Conclusions: The business of Internet healthcare exists in juxtaposition: research is slow, electronic modalities are quickly dated, and investors expect a high rate of return within three to five years. Successful organizations operating in the Internet healthcare space will develop long-term business plans and partnerships that address these barriers, and illustrate sustainability through value creation and Free Cash Flow (FCF).
Objectives: This presentation is designed to introduce researchers and innovators to two common barriers that hamper commercialization: transfer costs and opportunity costs. Successful businesses in the eHealth and mHealth space understand these costs. Businesses that do not are often forced to pivot (a term indicating that a company’s business model has changed), or simply cease to exist. Further, in order to attract investors and clients, it is important to understand the differences between Return on Investment (ROI), and Return on Invested Capital (ROIC).
Methods: By revisiting key milestones in the growth of Internet healthcare, this presentation will review the fundamentals of transfer and opportunity costs, and ROI and ROIC as they pertain to growth in this unique and evolving market.
Conclusions: The business of Internet healthcare exists in juxtaposition: research is slow, electronic modalities are quickly dated, and investors expect a high rate of return within three to five years. Successful organizations operating in the Internet healthcare space will develop long-term business plans and partnerships that address these barriers, and illustrate sustainability through value creation and Free Cash Flow (FCF).
Medicine 2.0® is happy to support and promote other conferences and workshops in this area. Contact us to produce, disseminate and promote your conference or workshop under this label and in this event series. In addition, we are always looking for hosts of future World Congresses. Medicine 2.0® is a registered trademark of JMIR Publications Inc., the leading academic ehealth publisher.
This work is licensed under a Creative Commons Attribution 3.0 License.